Philippe Gervais

5.0k total citations · 2 hit papers
37 papers, 2.5k citations indexed

About

Philippe Gervais is a scholar working on Radiology, Nuclear Medicine and Imaging, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Philippe Gervais has authored 37 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Physiology and 8 papers in Psychiatry and Mental health. Recurrent topics in Philippe Gervais's work include Medical Imaging Techniques and Applications (8 papers), Alzheimer's disease research and treatments (7 papers) and Advanced MRI Techniques and Applications (7 papers). Philippe Gervais is often cited by papers focused on Medical Imaging Techniques and Applications (8 papers), Alzheimer's disease research and treatments (7 papers) and Advanced MRI Techniques and Applications (7 papers). Philippe Gervais collaborates with scholars based in France, United States and Canada. Philippe Gervais's co-authors include Alexandre Gramfort, Alexandre Abraham, Gaël Varoquaux, Fabian Pedregosa, Jean Kossaifi, Michael Eickenberg, Andreas Mueller, Bertrand Thirion, Michel Bottlaender and Marie Sarazin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain and Neurology.

In The Last Decade

Philippe Gervais

32 papers receiving 2.5k citations

Hit Papers

Machine learning for neuroimaging with scikit-learn 2014 2026 2018 2022 2014 2016 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Gervais France 17 851 544 408 380 332 37 2.5k
Dominique Sappey‐Marinier France 29 546 0.6× 1.1k 2.1× 219 0.5× 198 0.5× 357 1.1× 83 2.4k
David B. Keator United States 27 910 1.1× 369 0.7× 158 0.4× 386 1.0× 522 1.6× 89 2.5k
Matthan W.A. Caan Netherlands 37 957 1.1× 1.3k 2.4× 335 0.8× 267 0.7× 329 1.0× 140 4.2k
Sang H. Lee United States 26 799 0.9× 404 0.7× 167 0.4× 362 1.0× 246 0.7× 128 2.8k
Xiaoying Wu China 19 786 0.9× 697 1.3× 330 0.8× 382 1.0× 507 1.5× 91 2.6k
Jean‐Marc Constans France 27 453 0.5× 1.0k 1.9× 351 0.9× 233 0.6× 314 0.9× 128 2.6k
Carlo Cavaliere Italy 32 691 0.8× 1.3k 2.4× 230 0.6× 314 0.8× 521 1.6× 179 3.5k
Amy Kuceyeski United States 25 1.3k 1.5× 880 1.6× 206 0.5× 345 0.9× 276 0.8× 86 2.3k
Kelvin K. Leung United Kingdom 24 728 0.9× 770 1.4× 490 1.2× 769 2.0× 222 0.7× 45 2.6k
Hosung Kim United States 27 856 1.0× 680 1.3× 167 0.4× 275 0.7× 159 0.5× 136 2.4k

Countries citing papers authored by Philippe Gervais

Since Specialization
Citations

This map shows the geographic impact of Philippe Gervais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Gervais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Gervais more than expected).

Fields of papers citing papers by Philippe Gervais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Gervais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Gervais. The network helps show where Philippe Gervais may publish in the future.

Co-authorship network of co-authors of Philippe Gervais

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Gervais. A scholar is included among the top collaborators of Philippe Gervais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Gervais. Philippe Gervais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lagarde, Julien, Mattéo Tonietto, Stéphane Lehéricy, et al.. (2024). Combined in vivo MRI assessment of locus coeruleus and nucleus basalis of Meynert integrity in amnestic Alzheimer’s disease, suspected-LATE and frontotemporal dementia. Alzheimer s Research & Therapy. 16(1). 97–97. 2 indexed citations
3.
Lagarde, Julien, Mattéo Tonietto, S. Rodrigo, et al.. (2023). Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study. Alzheimer s Research & Therapy. 15(1). 91–91. 8 indexed citations
4.
Boffa, Giacomo, Andrea Lazzarotto, Martina Absinta, et al.. (2023). Positron Emission Tomography with [18F]‐DPA‐714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease Progression. Annals of Neurology. 94(2). 366–383. 38 indexed citations
5.
Leroy, Claire, Sébastien Goutal, Philippe Gervais, et al.. (2023). A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans. European Journal of Nuclear Medicine and Molecular Imaging. 50(10). 3153–3154. 1 indexed citations
6.
Lagarde, Julien, Mattéo Tonietto, Cécile Tissot, et al.. (2022). Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer’s disease. Journal of Neurology Neurosurgery & Psychiatry. 93(5). 459–467. 40 indexed citations
7.
Marie, Solène, Laurent Becquemont, Céline Verstuyft, et al.. (2022). [11C]glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human liver and whole-body. Biomedicine & Pharmacotherapy. 156. 113994–113994. 5 indexed citations
8.
Ricigliano, Vito A. G., Emanuele Morena, Annalisa Colombi, et al.. (2021). Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation. Radiology. 301(1). 166–177. 112 indexed citations
9.
Lagarde, Julien, Mattéo Tonietto, Philippe Gervais, et al.. (2021). Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type. Translational Psychiatry. 11(1). 498–498. 9 indexed citations
10.
Caillé, Fabien, Philippe Gervais, Sylvain Auvity, et al.. (2020). Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans. Nuclear Medicine and Biology. 84-85. 20–27. 4 indexed citations
11.
Lagarde, Julien, Fabien Caillé, Philippe Gervais, et al.. (2019). [18F]-AV-1451 tau PET imaging in Alzheimer’s disease and suspected non-AD tauopathies using a late acquisition time window. Journal of Neurology. 266(12). 3087–3097. 9 indexed citations
12.
Lagarde, Julien, Stéphane Lehéricy, Romain Valabrègue, et al.. (2019). Early alteration of the locus coeruleus in phenotypic variants of Alzheimer’s disease. Annals of Clinical and Translational Neurology. 6(7). 1345–1351. 50 indexed citations
13.
Goutal, Sébastien, Oliver Langer, Sylvain Auvity, et al.. (2018). Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primates. Drug Delivery and Translational Research. 8(3). 536–542. 8 indexed citations
14.
Molin, Franck, Sébastien P. Blais, Véronique Tremblay, et al.. (2018). Cardiac Implantable Electronic Device Infection: Detailed Analysis of Cost Implications. Canadian Journal of Cardiology. 34(8). 1026–1032. 16 indexed citations
15.
Chassoux, Francine, Éric Artiges, Franck Semah, et al.. (2017). 18 F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy. Neurology. 88(11). 1045–1053. 60 indexed citations
16.
Hamelin, Lorraine, Julien Lagarde, Guillaume Dorothée, et al.. (2016). Early and protective microglial activation in Alzheimer’s disease: a prospective study using18F-DPA-714 PET imaging. Brain. 139(4). 1252–1264. 374 indexed citations breakdown →
17.
Tournier, Nicolas, Wadad Saba, Sébastien Goutal, et al.. (2015). Influence of P-Glycoprotein Inhibition or Deficiency at the Blood–Brain Barrier on 18F-2-Fluoro-2-Deoxy-d-glucose (18F-FDG) Brain Kinetics. The AAPS Journal. 17(3). 652–659. 7 indexed citations
18.
Kühnast, Bertrand, Annelaure Damont, Françoise Hinnen, et al.. (2011). [18F]DPA-714, [18F]PBR111 and [18F]FEDAA1106—Selective radioligands for imaging TSPO 18kDa with PET: Automated radiosynthesis on a TRACERLAb FX-FN synthesizer and quality controls. Applied Radiation and Isotopes. 70(3). 489–497. 50 indexed citations
19.
Ribeiro, Maria-João, Marcel Ricard, Sandrine Bourgeois, et al.. (2007). Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [11C]PE2I in healthy volunteers. Nuclear Medicine and Biology. 34(4). 465–470. 19 indexed citations
20.
Ribeiro, Maria-João, Marcel Ricard, Sandrine Bourgeois, et al.. (2005). Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers. European Journal of Nuclear Medicine and Molecular Imaging. 32(8). 952–958. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026